+
Site Tour
TENDYNE™
MITRAL VALVE
REPLACEMENT
TRANSCATHETER MITRAL VALVE
REPLACEMENT (TMVR)

 

Tendyne™ TMVR System is first-in-class technology designed to eliminate Mitral Regurgitation (MR),
offering selected patients with MR (≥ grade 3) a novel option for mitral valve replacement.

Now indicated for patients with severe MAC

Tendyne is now indicated for patients with severe Mitral Annular Calcification (MAC). This indication has received the CE Mark approval and allows us to offer Tendyne to a patient population with no alternative treatments, significantly improving their quality of life.
Hear firsthand from leading experts, Alison Duncan, Paolo Denti, Hendrik Ruge, and Christopher Klein as they provide their insights on Tendyne.

Connext
TV

CONNECT TO THE LATEST
IN STRUCTURAL HEART
THERAPY

Find out more

TV

Tendyne patient testimonial: Graham's story

Graham’s 10 years journey with Tendyne™ and Dr. Alison Duncan’s Insight

A decade of Tendyne: C. Klein and P. Denti

Tendyne: C. Klein and P. Denti share their experience

A decade of Tendyne: H. Ruge and A. Duncan

Tendyne: H. Ruge and A. Duncan share their experience

Transcatheter Mitral Valve implant

Transcatheter Mitral Valve implant : procedural and post-procedural echo guiding

Transcatheter Mitral Valve implant

Transcatheter Mitral Valve implant : patient selection and current evidence

Anatomical overview of the AV Valves

Anatomical overview of the AV Valves and structures

Screening Transmission | Mitral focus

Screening Transmission | Mitral focus

F. Maisano, M. Swaans, M. Adam. M. Weber

TriClip - AVVS 1 year 1 minute Tricuspid - Video

The most significant moments of the past year | Tricuspid focus

MitraClip - AVVS 1 year 1 minute Mitral - Video

The most significant moments of the past year | Mitral focus

AV Valves Summit 2024 | Closing of Day 2

AV  Valves Summit 2024 | Closing of Day 2

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

© Abbott 2025. All rights reserved. 9-EH-5-14381-01 05-2025 REV B

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline